Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0033774 (pruritus)
 14,546 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Infestation by Sarcoptes scabiei var. bovis in a farmer is reported. He presented with an intensely itching eruption of erythematous papules on forearm, neck and abdomen. An environmental investigation yielded that four of the farmer's cows had mange. Sarcoptes scabiei var. bovis was isolated from skin-scrapings of the cows. Histology from a self-induced lesion revealed that Sarcoptes scabiei var. bovis penetrates the human skin, but does not--in contrast to var. hominis--form burrows. This finding corresponds with the clinical picture. The mite lies subcorneally, compressing the thinned epidermis. The surrounding corneal tissue shows a marked exsudative reaction. The various ways in which mites may infest the human skin are discussed.
 ...
PMID:[Human infestation by Sarcoptes scabiei var. bovis (cattle itch mite)]. 51 47

Scabies (mange) is a skin disease of men and animals caused by microscopical acarids. There are mainly three species in Turkey, namely Demodex folliculorum, Sarcoptes scabiei var. hominis, and Pyemones ventricosus. They are easily transmissible from animals to men and from men to animals. These parasites may cause inflammation, thickening, scabrous and severe itching. Serious infectious and parasitic diseases are transmitted from dogs to men. We present a case of Demodectic mange in a dog in Beytepe University Campus.
 ...
PMID:[Demodectic mange in a dog in Beytepe University campus (author's transl)]. 55 11

The trial with Ivomec as a treatment against sarcoptic mange in rabbits gave very encouraging results. There was 100% clinical recovery in 31 rabbits that were treated with no cases of reinfestation. Even though there was no significant difference (P > 0.05) in weight gain between the treated and untreated groups, the efficacy of Ivomec was visually appreciated. Pruritus ceased one week post-treatment while total hair regrowth occurred after 6 weeks.
 ...
PMID:Ivomec, a treatment against rabbit mange. 129 25

Scabies is a mite infestation caused by Sarcoptes scabiei. Varieties of this organism can produce disease on 40 different species of animal, including humans. The organisms mature, burrow, and lay eggs. The newly hatched larvae mature and mate on the skin, causing itching and excoriated papules on humans, and mange, with crusts and oozing, on hair-bearing animals. Treatment with the gamma isomer of hexachlorobenzene or with pyrethrins is effective. Care must be taken that all infected or exposed individuals are treated. The role of fomites in the transmission of the disease is not clear. Most cases seem to be transmitted by close personal contact.
 ...
PMID:Scabies. 211 89

As llamas become more common in North America, veterinarians will be called on ever more frequently to deal with their dermatologic problems. Adherence to the basic tenets of the thorough dermatologic work up, including history, physical examination, skin scrapings, cytological examinations, fungal culture, skin biopsies, and assessing response to judiciously chosen trial therapies will offer the best opportunity of arriving at proper diagnoses. Special attention must be paid to the fact that llama skin bears some histological differences that may prove confusing to the uninitiated. A mild degree of hyperkeratosis, a prominent vascular plexus in the superficial dermis that is associated with mild perivascular mononuclear cell accumulations, and regional differences in sebaceous gland size and numbers, all are considered normal findings. Ectoparasites, including sarcoptic mange, chorioptic manage, and pediculosis, appear to be the most common causes of pruritus in the llama. Although ivermectin therapy would appear to be very effective for the treatment of scabies and, indeed, may work well against sucking lice, chorioptic mange and biting lice usually do not respond to this medication. Corticosteroids can be used to treat pruritus in the llama nonspecifically, using the anti-inflammatory dosages established in other species. These drugs are used most appropriately for the management of the allergies that we suspect occur in this species, until better alternative therapies can be developed. Variably pruritic focal areas of alopecia, exudation, and crusting suggest differential diagnoses including bacterial folliculitis and furunculosis, dermatophilosis, dermatophytosis, and coccidioimycosis. The diagnosis of bacterial problems often is made by assessing response to antibiotic therapy. Topical disinfectants and/or systemic penicillin or trimethoprim-sulfadiazine are indicated. Dermatophilosis is treated by cleaning and drying the leasions, applying topical antibiotics, and, occasionally, using parenteral penicillin and streptomycin. Dermatophytosis usually is treated with topical antibiotics only. Captan is one of several therapies of choice. There is no therapy presently available for coccidioidomycosis in the llama. Perhaps most perplexing is the fact that one of the most common dermatopathies seen in the llama is an idiopathic keratinizing disorder that, in some cases, is responsive to zinc supplementation. We have no real idea of the pathogenesis of this problem and recognize that some affected animals will not respond to supplementation.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Llama dermatology. 264 33

The incidence of mange in dairy buffalo in India has increased significantly in recent years. The authors record an outbreak of mange affecting a dairy herd stocking about 30,000 buffalo and 1000 cows. The mange mites were either Sarcoptes scabiei or Psoroptes ovis, or a mixed infestation of both. The morbidity rate was 5-30% varying from group to group, with 100% in a severely affected group. Signs noticed were progressive dermatitis, alopecia, keratinization, skin thickened and wrinkled, intense itching and marked loss of condition often ending in death. Great losses of young animals from mange and gastrointestinal nematodes are very common in dairy herds in India. In view of their economic importance, the activity of ivermectin against naturally occurring mange and parasitic infections of adult buffalo and buffalo calves was determined. Ivermectin was administered by subcutaneous injection (IVOMEC 1% w/v - MSD AGVET) at a dose of 200 mcg kg-1 body weight. The efficacy was ascertained from the disappearance of mites from skin scrapings and the reduction in numbers of worm eggs in the faeces. The results of the treatment were dramatic: the mites disappeared within 2 weeks of the drug being administered in the majority of animals, with marked improvement in skin lesions. Four buffalo which had their entire body surface affected with mange needed a second dose on Day 28 for complete recovery. The effect on the nematodes was equally spectacular, with infections of Neoascaris vitulorum, Trichostrongylidae, Oesophagostomum spp. and Bunostomum being eliminated within 1 week of treatment.
 ...
PMID:Efficacy of ivermectin against mange and gastrointestinal nematodes of buffalo (Bubalus bubalis). 274 1

Cows were infected twice with 600 and 500 nymphs and adults of a bovine strain of Psoroptes ovis with a nine-week interval. The haematological response and the non-specific mitogen- and antigen-induced responsiveness of the peripheral blood lymphocytes of the animals was followed. Dermal reactivity to P ovis antigen injection was studied five weeks after reinfection. After the first infection with 600 mites none of the infected animals developed clinical psoroptic mange but a leucocytosis developed, contributed to primarily by an eosinophilia and by a slight lymphocytosis. Antigen-induced lymphocyte blastogenesis was used to measure the antigen-sensitive cell population in peripheral blood and this population showed a maximum increase 10 days after infection; however, antigen-sensitive cells remained above normal levels until reinfection. Upon challenge infection with 500 mites the infected animals showed an immediate hypersensitivity type reaction with a marked pruritus, scratching and exudation. Thereafter the lesions healed rapidly and none of the animals developed clinical mange. This clinical reaction was accompanied by a secondary eosinophilia but no change was apparent in the other blood elements. A marked increase in the blastogenic response of the peripheral blood lymphocytes was also apparent and this peaked three weeks after challenge. Following the intradermal injection of P ovis antigen there was an immediate swelling of the injection site in all infected and control animals and skin thickness was maximal one hour after injection. Thereafter there was a clear distinction in dermal reactions between P ovis infected and control animals; after 48 hours reactions were not seen in the control animals while marked dermal reactions were still present in the P ovis infected group.
 ...
PMID:Haematological and immunological response of unrestrained cattle to Psoroptes ovis, the sheep scab mite. 338 72

Field efficacy of moxidectin injectable was evaluated in sheep naturally infected with both Psoroptes ovis and Sarcoptes ovis mange. Three groups of fifteen ewes were selected from the flock based on parasitological and clinical status. Group 1 remained as untreated controls. Group 2 animals received a subcutaneous injection of moxidectin at 0.2 mg/kg body weight on Day 0; Group 3 animals received 0.2 mg/kg moxidectin twice on Day 0 and Day 7. Efficacy was assessed by taking skin scrapings from each animal on Days -4, 0, 7, 14, 28 and 35 post treatment (P.T.) and counting viable mite stages and species. In both treated groups the signs of itching disappeared within seven days P.T. Rapid clinical improvement was associated with reduction in numbers of mites compared with initial score which was over 90%. However, in skin scrapings on Day 7 P.T. several live mites of both species were present. The second injection of moxidectin removed all living mites and skin scrapings from group 3 animals that were negative for all mites on days 14, 28 and 35. The weight gain on average in group 2 was 2.0 kg and in group 3 2.7 kg, during the 35 days of trial. Untreated control animals have lost on average 3.1 kg from the weight at start of trial. All untreated animals remained positive and suffered from intensive scratching, anorexia and moist active skin lesions. Therefore they were given an emergency moxidectin treatment on days 35 and 37 each animal receiving 0.2 mg/kg b.w., subcutaneously. Moxidectin in both tested doses was well tolerated and no local reaction on injection sites was observed.
 ...
PMID:[Effectiveness of moxidectin (Cydectin inj.) in mixed Psoroptes ovis and Sarcoptes ovis infestations in sheep]. 757 Dec 43

Pruritus is a common complaint associated with equine dermatoses. Self-mutilation results in alopecia, excoriations, scaling, and crusting; the aesthetic appearance of the horse is often ruined and the horse may be unfit for riding or showing. This article specifically addresses those pruritic dermatoses caused by allergies, including food allergy/intolerance, atopy and contact allergy, as well as by two ectoparasites, stick-tight fleas and rhabditic mange. The clinical signs, diagnostic tests, and treatment recommendations are discussed for each disorder. Insect hypersensitivity and pruritus associated with the other more common ectoparasites are covered in depth elsewhere in this issue.
 ...
PMID:Overview of equine pruritus. 763 58

Field efficacy of injectable moxidectin was evaluated in sheep naturally infested with both Psoroptes ovis and Sarcoptes scabiei var. ovis mange. Three groups of 15 ewes were selected from the flock based on parasitological and clinical status. Group 1 remained as untreated controls; Group 2 animals received a subcutaneous injection of moxidectin at 0.2 mg kg-1 body weight on Day 1; Group 3 animals received 0.2 mg kg-1 moxidectin twice on Day 1 and Day 7. Efficacy was assessed by taking skin scrapings from each animal on Days -4, 0, 7, 14, 28 and 35 post-treatment and counting viable mite stages and species. In both treated groups the signs of itching disappeared within 7 days post-treatment. Rapid clinical improvement was associated with reduction in numbers of mites compared with initial score which was over 90%. However, in skin scrapings on Day 7 post-treatment several live mites of both species were present. The second injection of moxidectin removed all living mites, and skin scrapings from Group 3 animals were negative for all mites on Days 14, 28 and 35. The weight gain on average was 2.0 kg in Group 2 and 2.7 kg in Group 3 during the 35 days of trial. Untreated control animals lost on average 3.1 kg from their weight at the start of the trial. All untreated animals remained positive and suffered from intensive scratching, anorexia and moist, active skin lesions. They were given an emergency moxidectin treatment on Days 35 and 42, each animal receiving 0.2 mg kg-1 body weight, subcutaneously.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Efficacy of injectable moxidectin against mixed (Psoroptes ovis and Sarcoptes scabiei var. ovis) mange infestation in sheep. 775 10


1 2 3 4 5 Next >>